Source: Fox News

With data collected from over 2.6 billion people around the world, a new study reveals that the risk of death from Covid is 79% lower in countries where HCQ treatment was widespread and used early in the disease, versus those where it has been limited. Dr Ramin Oskaoui discusses the tremendously positive outcomes that these countries are experiencing, compared to the United States.

Related: Kusi News: Dr. Simone Gold discusses benefits of Hydroxychloroquine after video showing efficacy was censored

Hydroxychloroquine works in high-risk patients, and saying otherwise is dangerous

Why the Smear Campaign Against Hydroxychloroquine?

Outsiders: Doctors, patients should be free to decide on whether to take hydroxychloroquine

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »